Adjuvant Immunotherapy for Cancer: Both Dendritic Cell-Priming and Check-Point Inhibitor Blockade Are Required for Immunotherapy

Proceedings of the Japan Academy Series B: Physical and Biological Sciences - Japan
doi 10.2183/pjab.94.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Academy

Related search

Dendritic Cell-Based Immunotherapy for Prostate Cancer

CA - A Cancer Journal for Clinicians
OncologyHematology
1999English

Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy

Journal of Immunology
AllergyImmunology
2001English

Cancer Immunotherapy: PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)

Advanced Materials
Mechanics of MaterialsMaterials ScienceNanotechnologyMechanical EngineeringNanoscience
2018English

Dendritic Cell-Based Immunotherapy

Cell Research
Cell BiologyMolecular Biology
2016English

CCL2 Blockade Augments Cancer Immunotherapy

Cancer Research
Cancer ResearchOncology
2009English

Immunotherapy of Cancer With Dendritic Cell-Based Vaccines

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1998English

Dendritic Cell-Based Immunotherapy of Breast Cancer: Modulation by CpG

2004English

Immunotherapy for Gastrointestinal Cancer

Gastroenterology
HepatologyGastroenterology
2019English

Immunotherapy for Cervical Cancer

BioDrugs
MedicineBiotechnologyPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy